Standard InChI: InChI=1S/C19H36N6O7/c1-19(28)7-29-18(13(27)16(19)24-2)32-15-11(22)5-10(21)14(12(15)26)31-17-9(20)4-3-8(30-17)6-25-23/h3,6,9-18,24,26-28H,4-5,7,20-23H2,1-2H3/b25-6-/t9-,10+,11-,12+,13-,14-,15+,16-,17-,18-,19+/m1/s1
Standard InChI Key: OPUPXCQFMKXPIR-NYPNNFHKSA-N
Associated Targets(non-human)
Escherichia coli 133304 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Pseudomonas aeruginosa 123386 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Klebsiella pneumoniae 43867 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Providencia 40 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Proteus mirabilis 3894 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Providencia rettgeri 925 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Serratia marcescens 3237 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Salmonella typhimurium 15756 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Bacillus subtilis 32866 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Staphylococcus aureus 210822 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Streptococcus pyogenes 16140 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Trichomonas vaginalis 2376 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Entamoeba histolytica 2676 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 460.53
Molecular Weight (Monoisotopic): 460.2645
AlogP: -3.87
#Rotatable Bonds: 6
Polar Surface Area: 226.08
Molecular Species: BASE
HBA: 13
HBD: 8
#RO5 Violations: 2
HBA (Lipinski): 13
HBD (Lipinski): 12
#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.55
CX Basic pKa: 9.68
CX LogP: -4.18
CX LogD: -9.87
Aromatic Rings: 0
Heavy Atoms: 32
QED Weighted: 0.11
Np Likeness Score: 1.54
References
1.Davies DH, Mallams AK, Counelis M, Loebenberg D, Moss EL, Waitz JA.. (1978) Semisynthetic aminoglycoside antibacterials. 6. Synthesis of sisomicin, Antibiotic G-52, and novel 6'-substituted analogues of sisomicin from aminoglycoside 66-40C., 21 (2):[PMID:413921][10.1021/jm00200a009]